Cancer develops through a series of genetic mutations that disrupt the normal regulation of cell division and specialization. These mutations can be inherited or caused by environmental carcinogens and result in the activation of oncogenes and inactivation of tumor suppressor genes. This loss of cell cycle control leads to uncontrolled cell growth and a lack of specialization, forming malignant tumor masses. While some screening tests can help detect certain cancers early, biomarkers alone are not sufficient for diagnosis - biopsy and pathological examination are needed to confirm cancer. Chemotherapy non-selectively targets rapidly dividing cells but also damages normal cells, causing side effects.
Cancer develops through a series of genetic mutations that disrupt the normal regulation of cell division and specialization. These mutations can be inherited or caused by environmental carcinogens and result in the activation of oncogenes and inactivation of tumor suppressor genes. This loss of cell cycle control leads to uncontrolled cell growth and a lack of specialization, forming malignant tumor masses. While some screening tests can help detect certain cancers early, biomarkers alone are not sufficient for diagnosis - biopsy and pathological examination are needed to confirm cancer. Chemotherapy non-selectively targets rapidly dividing cells but also damages normal cells, causing side effects.
Cancer develops through a series of genetic mutations that disrupt the normal regulation of cell division and specialization. These mutations can be inherited or caused by environmental carcinogens and result in the activation of oncogenes and inactivation of tumor suppressor genes. This loss of cell cycle control leads to uncontrolled cell growth and a lack of specialization, forming malignant tumor masses. While some screening tests can help detect certain cancers early, biomarkers alone are not sufficient for diagnosis - biopsy and pathological examination are needed to confirm cancer. Chemotherapy non-selectively targets rapidly dividing cells but also damages normal cells, causing side effects.
INTRODUCTION Some of our carcinogens for example UV (a
carcinogen), ultraviolet light has the capacity to make thymine dimers in our DNA. This thymine dimer will give way to form aberrant gene expression and it could also cause cancers.
A brief review of a cell cycle is associated with
multiplication of cells, so we have the interphase and the mitotic phase of the cell cycle. Now, the cell cycle should be tightly regulated, and if its not, there will be an overproduction of cells, the buildup of cells since you have a lot of cells that are formed from time to time, you create a mass and that mass is what we call a tumor. In a population, there are 33 of those 100 people to develop cancer. Diagnosis and treatment now we have what we call personalized medicine in treating cancer because several cancers are based on the individual genetic of a person. Here also is also the application of pharmacogenomics in which we apply treatment or medications to a person based on their genotype and genetic makeup of an individual because a lot of us has a lot of variations in terms of our genetic content.
Cancer is a highly genetic disease, although
some cancers are due to infectious in origin. In medicine, we have the strict usage of the terms cause and association. When we say cause that type of substance or that etiology would surely cause a certain disease, when you say A more appropriate term for tumor is association, it can be potential risk factors that neoplasms. Now neoplasms are the more could contribute to the development of a certain appropriate and pathologic term when you say disease. growth or tumors. Neoplasms can be divided in to a benign neoplasm and a malignant neoplasm.
What is the differentiating term of a benign and
malignant? It’s considered benign if it has the least to no capacity of invading surrounding tissue and potentially metastasizing (the spread of the cancer cells to distant areas) to other organs. A tumor is considered to be cancerous or malignant if it infiltrates nearby tissue, it has the ability to spread or to invade nearby tissue and can even metastasize. CANCER CAUSING GENES
Oncogenes – result into cancer, abnormal form
of a proto-oncogene. Proto-oncogenes – normal genes, that play role in our basic machinery to ensure that our cells that would multiply, and ones these proto- oncogenes will be mutated and will always be activated it now results to an oncogene.
Tumor suppressor genes are normal genes –
they balance the proto-oncogenes. Prevent cell division, and control cell growth/multiplication. CELL CYCLE CONTROL LOSS OF CELL CYCLE CONTROL Telomeres – portion of chromosomes that are found at the tips of the chromosomes. Telomerase – enzymes that add telomeres at the end of the chromosome.
Telomeres would act as a protection for the
chromosome. Meaning if you add telomeres, it increases the survivability of the cell. It makes the chromosome of the cell somewhat protected from harm.
As a principle of aging, has also something to do
with the telomere. As we age, the length of the telomeres would usually shorten but for cancer cells, but cancer cells would make a way that they have greater survivability over the normal cell, so they add up telomeres at the end of its chromosome.
INHERITED VS SPORADIC CANCER
We have several stem cells. Now stem cells are
pluripotent cells meaning they can form several histologic types of cell; neurons, fibroblasts, or even abnormal cancer cells.
During the formation of these cells, cell division
of course must take place. But what we want is that we need to have a controlled cell division, not too much not too less. If you have too much of that cell division, that’s the main problem of cancer. TELOMERES AND TELOMERASE ORIGIN OF CANCER When you say specialization, it doesn’t differentiate into its destined cell like a fibroblast, neurons, or RBC, or epithelial cell.
a. Healthy specialized cell
b. Other mutations c. Invasion and metastasis
CHARACTERISTICS OF CANCER CELLS
We have normal healthy epithelial cells, cells
that would line the surfaces of our body (skin, mucous membranes, GI tract). Any cell can develop cancer, the most common cancer is due to the abnormal growth of the epithelial ANGIOGENESIS: cells. Now, how does cancer develop? We 1. Nurture the tumor. have a certain trigger, can be an inherited 2. Promote metastasis mutation (germline mutation), or an environmental carcinogen that would cause mutation (occurs sporadically/ somatic mutation).
You have now an environmental insult that
would cost mutation, and it can result into the activation of an oncogene and inactivation of the tumor suppressor gene. Now, this mutation will result in to loss of cell division control and loss of specialization, and malignancy often results from a series of mutation, an infected cells divides more than the cell types and it descends form and eventually loses its specialized characteristics. ORIGIN OF CANCER CELLS
In the top portion of the illustration, we have ff.
cells: neurons, astrocytes, and oligodendrocytes. Astrocytes and oligodendrocytes are part of the glial cells of the brain. Now, in the developing brain, stem cells divide to self-renew itself and give rise to early progenitor cells. Now these early progenitor cells, would later in turn divide and develop in to a late progenitor cell. Now, the earlier the cell lineage, you have the CD133+ or cluster of differentiation. It’s a marker that it is an earlier lineage of the cell meaning it’s not yet differentiated. So, these late progenitor cells would lose later on the CD133 self-surface marker. Later on the late progenitors will divide UNCONTROLLED TISSUE REPAIR MAY CD133-. CAUSE CANCER
In a cancer, there is no specialization. The
marker would be the positivity of CD133. CANCER BY LOSS OF SPECIALIZATION
DEDIFFERENTIATION REVERSES SPECIALIZATION
ONCOGENES
CD133- is a specialized type of cell.
CANCERS FORM SHIFTING BALANCE OF CELL TYPES IN A TISSUE FUSION PROTEINS But these are not a conclusive recommendations. For a certain regimen/medication to be prescribed, it should skin cancer is a regular inspection of the skin be backed up with good evidence that it can to check for any abnormal growth of moles or prevent cancers. nevus. Lung cancer is usually CT scan but it is not usually routinely performed. Prostrate cancer is PSA or examination of the prostate.
Non-selectively – they can also potentially cause
the destruction of normal dividing cells such as the cells of the intestines and our skin. That’s why it could result into several side effects.
The most common side effect of chemotherapy is
nausea and vomiting. We have several drugs to counteract the side effects, which is ondansetron – a type of drug that is ant-emetic that prevents nausea and vomiting for the treatment the chemotherapy-induced nausea and vomiting.
We have several tumor markers are utilized in
cancer, but they are not used as a cancer screening (not all of them). Very good example of a tumor marker in which we can use as a screening is the prostate-specific antigen (PSA) – used in the screening test for cancer. For breast cancer the screening test is mammography for older women and breast ultrasound for younger women. For colon cancer we have the FOBT Fecal Occult Blood Test, colonoscopy, or sigmoidoscopy. For